Annual accounts
Full accounts
31/12/2025Filing deadline
Made up to 31/12/2023Due 31/12/2025
- Next accounts made up to
- 31/12/2024
- Last accounts made up to
- 31/12/2023
MEDPHARM LIMITED
Active- 03783386Copy
Copy
Registry details
Reference data exactly as held at Companies House.
Copy registry details
- Registered office
- Unit 3, Chancellor Court 50 Occam Road, Surrey Research Park, Guildford, Surrey GU2 7AB
- Classification (SIC)
- Research and experimental development on biotechnology (72.11 - SIC 2007)
- Accounts type
- Full
Company activity
The 4 most recent documents filed at Companies House.
Pre-Score for UK companies is coming soon
- 04/04/2026View PDF (1 pages)
Compulsory strike-off action has been discontinued
- 17/03/2026View PDF (1 pages)
First Gazette notice for compulsory strike-off
- 26/09/2025View PDF (3 pages)
Confirmation statement made on 2025-06-07 with no updates
- 19/09/2025View PDF (2 pages)
Director's details changed for David John Parker on 2025-09-18
Coming soon
What Pre-Score will tell you
- Whether the filed accounts are strengthening or weakening year on year.
- Whether this company files on time, and how often its record changes.
- How its officers and controlling parties connect to other UK companies.
Accounts and confirmation statement
The two filings Companies House requires every year, and where each one stands against its deadline today.
268 days overdue
Confirmation statement
Confirms the registry record is up to date
- Next statement date
- 07/06/2026
- Last statement dated
- 31/12/2023
Financial performance
The latest figures MEDPHARM LIMITED filed. Okredo holds filed accounts data for 2022–2024; the year-by-year record is on the financials page.
Net Assets
£-32.50M2024
-416.45%vs 20232023: £-6.29M
Total Assets
£11.26M2024
8.24%vs 20232023: £10.40M
Cash in Bank
£216.67K2024
-62.34%vs 20232023: £575.27K
Total Liabilities
£41.46M2024
198.04%vs 20232023: £13.91M
Employees
782024
-16vs 20232023: 94
Of the 4 measures with an earlier filing to compare against, 2 rose and 2 fell. Total liabilities moved furthest, up 198.04% on 2023. See the full financial analysis for MEDPHARM LIMITED.
The full financial record
Four ways through MEDPHARM LIMITED's filed accounts — the year-by-year numbers, the compound rates and the ratios behind them.
Cash in Bank · -52.9% a year (CAGR)Three-year trend, 2022–2024Every measure end to end across 2022, 2023 and 2024, with the compound rate behind each one.See what moved5 chartsCharts by indicator5 filed indicators plotted year by year, 2022–2024.Plot the figuresNothing estimatedRatios from the filed figures5 ratios computed from this company's own reported amounts, each shown against the year it was derived from.Check the ratios5 × 3 yearsEvery figure by yearAll 5 measures Okredo tracks across 3 reported years, exactly as filed.Open the table
Employees
Headcount as reported to Companies House for 2022–2024.
| Year | Employees | Change |
|---|---|---|
| 2024 | 78 | -16 |
| 2023 | 94 | -21 |
| 2022 | 115 | – |
Reported employee count decreased from 115 in 2022 to 78 in 2024. See how headcount moved alongside the reported financials.
Credit report
It is a professional assessment of the company 's performance, revealing company's potential and risks, showing it's past experiences and revealing future prospects.
- Company potential
- Risk indicators
- Past performance
- Future prospects
Officers
25Directors, secretaries and other appointed officers, with the period each has served.
| Person | Role | Period | Connected companies |
|---|---|---|---|
| Corporate Secretary | 14/07/2015–08/10/2021 | 103 | |
| Nominee Secretary | 07/06/1999–25/06/1999 | 68517 | |
| Nominee Director | 07/06/1999–25/06/1999 | 67500 | |
| Director | 27/04/2006–30/08/2013 | 21 | |
| Director | 20/01/2003–17/01/2008 | 6 | |
| Director | 25/06/1999–17/01/2024 | 8 | |
| Director | 07/10/2016–01/05/2018 | 20 | |
| Director | 28/01/2002–01/07/2002 | 13 | |
| Director | 25/06/1999–17/01/2024 | 11 | |
| Director | 01/08/2001–20/01/2003 | 6 | |
| Director | 01/08/2001–20/05/2009 | 1 | |
| Director | 01/08/2003–27/10/2005 | 9 | |
| Director | 13/09/2021–31/03/2023 | 1 | |
| Director | 08/12/2018–Present | 1 | |
| Director | 08/12/2018–18/09/2025 | 1 | |
| Director | 31/10/2024–18/09/2025 | 4 | |
| Secretary | 30/06/2005–29/04/2015 | 5 | |
| Secretary | 25/06/1999–30/06/2005 | 2 | |
| Director | 25/06/1999–11/08/2003 | 0 | |
| Director | 25/09/2013–15/03/2018 | 0 | |
| Director | 27/06/2024–31/03/2025 | 1 | |
| Director | 27/06/2024–31/10/2024 | 1 | |
| Secretary | 27/06/2024–31/10/2024 | 0 | |
| Secretary | 31/10/2024–18/09/2025 | 0 | |
| Director | 01/04/2025–Present | 1 |
Persons with significant control
1Individuals or entities with significant control over the company, as declared to Companies House.
| Person | Period | Connected companies |
|---|---|---|
| 06/04/2016–15/03/2018 | 8 |
Filing history and recent activity
Every document on the Companies House record, newest first.
- Filings on record
- 37 Since 03/01/2023
- Last 12 months
- 3 -12 vs the year before
- Most recent filing
- 04/04/2026 5 months ago
What changed in the last year
- Insolvency or dissolution (2)Latest 04/04/2026
- Confirmation statementLatest 26/09/2025
Filing timeline
- 04/04/2026View PDF (1 pages)
Compulsory strike-off action has been discontinued
- 17/03/2026View PDF (1 pages)
First Gazette notice for compulsory strike-off
- 26/09/2025View PDF (3 pages)
Confirmation statement made on 2025-06-07 with no updates
- 19/09/2025View PDF (2 pages)
Director's details changed for David John Parker on 2025-09-18
- 19/09/2025View PDF (1 pages)
Termination of appointment of Edward Hjerpe as a director on 2025-03-31
- 19/09/2025View PDF (1 pages)
Termination of appointment of Patrick Walsh as a secretary on 2025-09-18
- 19/09/2025View PDF (2 pages)
Appointment of William Douglas Humphries as a director on 2025-04-01
- 19/09/2025View PDF (1 pages)
Termination of appointment of Trevor Wahlbrink as a director on 2025-09-18
- 19/09/2025View PDF (1 pages)
Termination of appointment of Patrick D. Walsh as a director on 2025-09-18
- 27/08/2025View PDF (1 pages)
Compulsory strike-off action has been discontinued
- 26/08/2025View PDF (1 pages)
First Gazette notice for compulsory strike-off
- 09/05/2025View PDF (2 pages)
Director's details changed for Trevor Wahlbrink on 2024-08-13
Showing 12 of 37 filings
See when the next accounts and confirmation statement are due
Similar companies
4 UK companies are similar to MEDPHARM LIMITED, sharing the same company status (Active), the same industry sector and activity group (Research and experimental development on biotechnology) and a comparable number of employees. The 4 closest matches are shown below to help you compare competitors and industry peers.
HOBBS REHABILITATION LIMITED
ActiveBridgets Farm Offices Bridgets Lane, Martyr Worthy, Winchester, Hampshire SO21 1AR
- Activity
- Other research and experimental development on natural sciences and engineering
- Company no.
- 05323651
- Incorporated
- 04/01/2005
- Employees
- 79
MOA TECHNOLOGY LIMITED
ActiveThe Bellhouse Building The Magdalen Centre, The Oxford Science Park, 1 Robert Robinson Avenue, Oxford OX4 4GA
- Activity
- Research and experimental development on biotechnology
- Company no.
- 10895764
- Incorporated
- 02/08/2017
- Employees
- 83
ORIGIO LIMITED
ActiveDelta Park Concorde Way, Segensworth North, Fareham, Hampshire PO15 5RL
- Activity
- Research and experimental development on biotechnology
- Company no.
- 03221787
- Incorporated
- 09/07/1996
- Employees
- 82
UBC LATE STAGE (UK) LIMITED
Active12 New Fetter Lane, London EC4A 1JP
- Activity
- Research and experimental development on biotechnology
- Company no.
- 06776534
- Incorporated
- 18/12/2008
- Employees
- 86
About MEDPHARM LIMITED
A short description of the company, written from its Companies House record.
MEDPHARM LIMITED is a private limited company registered in the United Kingdom, based in Unit 3, Chancellor Court 50 Occam Road, Surrey Research Park, Guildford, Surrey GU2 7AB. Companies House classifies its business as Research and experimental development on biotechnology. It has been on the register for 27 years 3 months.
The register currently records it as active. Its 2024 accounts report net assets of £-32.50M and 78 employees. Its accounts are past the filing deadline shown on the registry record.
MEDPHARM LIMITED: frequently asked questions
Answered from this company's own registry record and filed figures.
What does MEDPHARM LIMITED do?
Companies House records MEDPHARM LIMITED under one registered business activity: Research and experimental development on biotechnology (72.11 - SIC 2007).
Is MEDPHARM LIMITED still active?
MEDPHARM LIMITED is recorded as active on the Companies House register, and has been on it since 07/06/1999.
What are MEDPHARM LIMITED's latest reported financials?
The most recent accounts Okredo holds cover 2024 and report net assets of £-32.50M, total assets of £11.26M, cash in bank of £216.67K and total liabilities of £41.46M.
When did MEDPHARM LIMITED last file with Companies House?
The most recent document on the record is dated 04/04/2026: Compulsory strike-off action has been discontinued, 5 months ago.
When are MEDPHARM LIMITED's next filings due?
On the current registry record, accounts are due by 31/12/2025, which has passed.
Who runs MEDPHARM LIMITED?
Companies House lists 25 officers (2 currently in post) and 1 person with significant control (0 current).